Literature DB >> 2543212

The effect of respiratory viral infections on patients with cystic fibrosis.

B W Ramsey1, E J Gore, A L Smith, M K Cooney, G J Redding, H Foy.   

Abstract

We examined, in a 2-year prospective study, the frequency of respiratory viral infections in 19 school-age patients with cystic fibrosis and their unaffected siblings. At 2-month intervals throughout the study period, pulmonary function tests, oropharyngeal cultures, and serologic tests for respiratory viruses were performed in all subjects. Quantitative sputum cultures for bacteria were performed in subjects with cystic fibrosis. The same laboratory specimens were also collected at the time of all acute respiratory illnesses. Over the 2-year period, 398 viral cultures and serum samples were collected, 210 from patients with cystic fibrosis and 188 from their siblings. The frequency of culture-documented and seropositive viral infections was not significantly different between patients with cystic fibrosis and their siblings. The patients with the highest frequency of viral infection were younger and had the lowest rate of decline in lung function and severity score. We conclude that school-age patients with cystic fibrosis are no more susceptible to viral infections than their unaffected siblings. We were unable to demonstrate any significant adverse effect of respiratory viral infections on pulmonary function in 19 patients with cystic fibrosis aged 5 to 21 years.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543212     DOI: 10.1001/archpedi.1989.02150180040017

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  42 in total

Review 1.  Sinus disease in cystic fibrosis.

Authors:  G K Mak; N R Henig
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

2.  Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.

Authors:  Michael E Speer
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

Review 3.  Spectrum of viral infections in patients with cystic fibrosis.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 4.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis.

Authors:  Ixsy A Ramirez; Lindsay J Caverly; Lindsay L Caverly; Linda M Kalikin; Adam M Goldsmith; Toby C Lewis; David T Burke; John J LiPuma; Uma S Sajjan; Marc B Hershenson
Journal:  Ann Am Thorac Soc       Date:  2014-05

Review 6.  Vaccines for preventing influenza in people with cystic fibrosis.

Authors:  Poonam Dharmaraj; Rosalind L Smyth
Journal:  Cochrane Database Syst Rev       Date:  2014-03-06

7.  Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.

Authors:  H K Johansen; N Høiby
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

8.  Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer.

Authors:  J Rosenecker; K H Harms; R M Bertele; A Pohl-Koppe; E v Mutius; D Adam; T Nicolai
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

Review 9.  The impact of respiratory viral infections in patients with cystic fibrosis.

Authors:  C G Prober
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 10.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.